Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV (with Y. V. Liu, M. J. Massare, T. Kort, M. Nathan, L. Wang, and G. Smith), Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV (2011)

PDF

Commentary on immune system associated diseases caused by viruses: The Role of EBV (with J. K. Li), Commentary on immune system associated diseases caused by viruses: The Role of EBV (2011)

Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin (with Y. Kumaki, M. K. Wandersee, A. J. Smith, Y. Zhou, G. Simmons, N. M. Nelson, K. W. Bailey, Z. G. Vest, J. K. Li, P. K. Chan, and D. F. Smee), Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin (2011)

In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections (with Y. Kumaki, C. W. Day, D. F. Smee, and J. D. Morrey), In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections (2011)

Link

Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy (with Y. Kumaki), Recent developments in anti-severe acute respiratory syndrome coronavirus chemotherapy (2011)

View More »